Clinical Trials
> Gastric/Esophageal Cancer

EMR 100070-008

A Phase III open-label, multicenter trial of avelumab (MSB0010718C) as a third-line treatment of unresectable, recurrent, or metastatic gastric or gastroesophageal junction adenocarcinoma can also send patients to Doctors Imaging for CTs MRIs etc- no bone scan-

EMR 100070-007

A Phase III open-label, multicenter trial of maintenance therapy with avelumab (MSB0010718c) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic, adenocarcinoma of the stomach, or of the gastro esophageal junction .


A Phase1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (Bladder, Colon,Gastric,Renal)